These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 18281657)
1. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer. Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238 [TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Lu H; Shu XO; Cui Y; Kataoka N; Wen W; Cai Q; Ruan ZX; Gao YT; Zheng W Cancer Res; 2005 Jun; 65(12):5015-9. PubMed ID: 15958542 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174 [TBL] [Abstract][Full Text] [Related]
8. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer. Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population. Dong J; Dai J; Shu Y; Pan S; Xu L; Chen W; Wang Y; Jin G; Ma H; Zhang M; Hu Z; Shen H Carcinogenesis; 2010 Jun; 31(6):1080-6. PubMed ID: 20400478 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114 [TBL] [Abstract][Full Text] [Related]
11. VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Kim YH; Kim MA; Park IA; Park WY; Kim JW; Kim SC; Park NH; Song YS; Kang SB Gynecol Oncol; 2010 Nov; 119(2):232-6. PubMed ID: 20797778 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253 [TBL] [Abstract][Full Text] [Related]
13. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Lu C; Spitz MR; Zhao H; Dong Q; Truong M; Chang JY; Blumenschein GR; Hong WK; Wu X Cancer; 2006 Jan; 106(2):441-7. PubMed ID: 16342067 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer. Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326 [TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer. Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Goto I; Yoneda S; Yamamoto M; Kawajiri K Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015 [TBL] [Abstract][Full Text] [Related]
18. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma. Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B; Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590 [TBL] [Abstract][Full Text] [Related]
19. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Zhou W; Heist RS; Liu G; Park S; Neuberg DS; Asomaning K; Wain JC; Lynch TJ; Christiani DC Lung Cancer; 2006 Sep; 53(3):375-80. PubMed ID: 16814423 [TBL] [Abstract][Full Text] [Related]
20. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Bieniasz M; Oszajca K; Eusebio M; Kordiak J; Bartkowiak J; Szemraj J Lung Cancer; 2009 Dec; 66(3):319-26. PubMed ID: 19324447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]